Prednisone-Treated Duchenne Muscular Dystrophy

J Gordon Millichap

doi:10.15844/pedneurbriefs-5-6-5

Prednisone-Treated Duchenne Muscular Dystrophy

Pediatric Neurology Briefs

Volume 5 (1991): Issue 6

By: J Gordon Millichap

Open Access

|Jun 1991

Abstract

The immunosuppressant/antiinflammatory effects of prednisone were studied in 33 patients with Duchenne muscular dystrophy (ages 5 to 15 years) at the conclusion of a six month treatment trial at the Department of Neurology, Division of Neuromuscular Disease, Ohio State University College of Medicine, Columbus, OH.

References

Kissel JT Burrow KL Rammohan KW Mendell JR Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group Neurology 1991 May 41 5 667 72 2027481 10.1212/WNL.41.5.667
Open DOI Search in Google Scholar Back to article
Burrow KL Coovert DD Klein CJ Bulman DE Kissel JT Rammohan KW Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group Neurology 1991 May 41 5 661 6 1781820 10.1212/WNL.41.5.661
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-5-6-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 44 - 44

Published on: Jun 1, 1991

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Duchenne Muscular Dystrophy,

Low-Dose Prednisone Group,

Immunologic Mechanisms

© 1991 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 5 (1991): Issue 6